The drama involving Fannie Mae and Freddie Mac continues this week with a new round of hearings about the affordability of housing in the U.S. We're also seeing two... Read More

"Not all commodities are created equal," a Goldman Sachs Goal Kickstart report under the same name observed. On the week, copper and oil, both with economic correlation factors to... Read More

If there's one topic that's mentioned more than most in the world of value investing, it's the long-term outlook required. All of the great value investors have tried to... Read More

Margaret Thatcher famously stated ":“Socialists are happy until they run out of other people's money." With Venezuela we might have a new quote "until they run out of other... Read More

    Already on the defensive due to a persistent failure to achieve its stated policy aims, the US Fed was subject to much fresh criticism over the past week, including... Read More

Royal Bank of Scotland Group plc (NYSE:RBS) (LON:RBS) is easily the biggest bank in the world still suffering from a financial crisis hangover. While its UK peer, Lloyds Banking... Read More

According to Kevin Gardiner of Rothschild, the current weakness in the U.S. economy is not likely to last more than a few months Read More

State Street Corp. received some bad news from the U.S. Securities and Exchange Commission, receiving a Wells notice regarding its solicitation of business in the public pension plan domain. State... Read More

Is volatility management a key statistic to pay attention to above absolute returns? When making allocation decisions there is a definite disadvantage to filtering hedge fund performance from the standpoint of... Read More

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) raised the stakes in its hostile bid for Allergan, Inc. (NYSE:AGN), to $58.30 per share, bringing the total bid to $166.16 per share... Read More